CLE ACCREDITATION
Accreditation will be sought in those jurisdictions
requested by registrants which have continuing
education requirements. To request credit, please
indicate on the Registration Form.
This conference has been approved in accordance with the requirements of the NewYork State Continuing Legal Education Board for a maximum of 15.5 credit hours for the conference and 4.0 additional credit hours for each workshop.
ACI certifies that this activity has been approved for MCLE credit by the State Bar of California in the amount of 12.75 credit hours for the conference and 3.5 additional credit hours for each workshop.
Drug & Medical Device Litigation Conference News
Recent news:
- New Federal Rule of Evidence 502, limiting attorney-client privilege and work product waivers was signed into law on September 19, 2008
- US DOJ revises its corporate charging guidelines
- The Financial Accounting Standards Board (FASB) is proposing that drug manufacturers be required to disclose more information about lawsuits and be more specific about damages they might have to pay
- Drug manufacturers advised to proceed cautiously in distributing journal articles that describe off-label product indications until FDA finalizes guidance on what practices are acceptable
- Wyeth v. Levine Supreme Court preemption cases scheduled for oral arguments
- Congress seeks to overhaul the FDA and give the agency more powers
- Qui tam off-label suits not being met favorably by courts.
- Pennsylvania court rules that a brand name manufacture can be liable to plaintiffs who purchases drugs manufactured by a third party
- Congress threatens to abolish the preemption defense
- NJ Supreme Court rejects certification of a medical monitoring class in coxx2 litigation
Topics at the 2008 Drug & Medical Device Litigation conference will include:
- Assessing the influence of Congress and the 2008 election on product liability litigation
- Managing outside counsel fees and controlling discovery costs
- Understanding how jurors perceive the drug and device industries and how to use that knowledge in devising litigation strategies
- Preparing corporate witnesses for litigation
The 2008 conference will feature faculty from these industry leaders:
AGA Medical, Alcon, Allergan, Bausch & Lomb, Bayer, Boston Scientific, Cardinal Health, EMD Serono, Johnson & Johnson, Medtronic, Novartis, Novo Nordisk, Pfizer, Roche, Schering-Plough, Shire, St. Jude Medical, Stryker, Wyeth
Notable speakers will include:
Gerald Masoudi, Judge Mark E. Fuller, Judge Harry D. Leinenweber, Judge Charles R. Wolle, Judge Donovan W. Frank, Judge Janis Graham Jack, Judge Marcia S. Krieger, Judge John R. Tunheim, Judge Mark I. Bernstein